| Citation: |
SHA Feiyan, CHEN Peipei, LI Wen, XIE Renbing. Values of CHA2DS2-VASc score and Global Registry of Acute Coronary Events risk score in predicting poor prognosis of patients with atrial fibrillation after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 46-51. DOI: 10.7619/jcmp.20222276
|
To investigate the values of CHA2DS2-VASc score and the Global Registry of Acute Coronary Events (GRACE) risk score in predicting the poor prognosis of patients with atrial fibrillation after percutaneous coronary intervention (PCI).
A total of 180 patients diagnosed as atrial fibrillation and treated with PCI were selected as research objects, and CHA2DS2-VASc score and GRACE risk score were evaluated after hospital admission. Patients were followed up for 12 months, with the major adverse cardiac events (MACE) as the primary outcome index and all-cause mortality as the secondary outcome index. The patients were divided into different subgroups according to the occurrence of MACE and death, and the general materials were compared between subgroups. Cox proportional hazard model was used to evaluate the values of CHA2DS2-VASc score and GRACE risk score in predicting outcome indexes. The receiver operating characteristic (ROC) curve was drawn and the area under the curve (AUC) was calculated, and the predictive efficiencies of CHA2DS2-VASc score and GRACE risk score for outcome indexes were evaluated.
A total of 21 patients (11.7%) with MACE were enrolled in the MACE group, and 159 patients without MACE were enrolled in the non-MACE group; the age, incidence of congestive heart failure, CHA2DS2-VASc score and GRACE risk score in the MACE group were significantly higher than those in the non-MACE group (P < 0.05). A total of 10 dead patients (5.6%) were enrolled in the death group, and the 170 survival patients were enrolled in the survival group; the age, CHA2DS2-VASc score and GRACE risk score in the death group were significantly higher than those in the survival group (P < 0.05). Cox proportional hazard model showed that the increases of CHA2DS2-VASc score and GRACE risk score were related to the increase of risk of MACE (HR=2.056, 1.076; 95%CI, 1.558 to 2.713, 1.048 to 1.104; P < 0.001), and the increases of CHA2DS2-VASc score and GRACE risk score were also significantly associated with the increase of all-cause mortality (HR=2.949, 1.114; 95%CI, 1.983 to 4.387, 1.067 to 1.163; P < 0.001). ROC curve showed that the AUC values of CHA2DS2-VASc score combined with GRACE risk score in predicting MACE and all-cause mortality were 0.856 and 0.943 respectively, the sensitivity values were 85.7% and 80.0% respectively, and specificity values were 73.0% and 90.6% respectively.
Increase of CHA2DS2-VASc score and GRACE risk score is associated with increase of risks of MACE and all-cause mortality in patients with atrial fibrillation after PCI, and the combination of the two scoring methods has high predictive values for MACE and all-cause mortality in patients with atrial fibrillation after PCI.
| [1] |
CAPODANNO D, HUBER K, MEHRAN R, et al. Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2019, 74(1): 83-99. doi: 10.1016/j.jacc.2019.05.016
|
| [2] |
JANUARY C T, WANN L S, CALKINS H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society[J]. J Am Coll Cardiol, 2019, 74(1): e66-e93.
|
| [3] |
GUERRA F, SCAPPINI L, MAOLO A, et al. CHA(2)DS(2)-VASc risk factors as predictors of stroke after acute coronary syndrome: a systematic review and meta-analysis[J]. Eur Heart J Acute Cardiovasc Care, 2018, 7(3): 264-274. doi: 10.1177/2048872616673536
|
| [4] |
PENG H, SUN Z J, CHEN H, et al. Usefulness of the CHA2DS2-VASc score to predict adverse outcomes in acute coronary syndrome patients without atrial fibrillation undergoing percutaneous coronary intervention[J]. Am J Cardiol, 2019, 124(4): 476-484. doi: 10.1016/j.amjcard.2019.05.036
|
| [5] |
IBÁNEZ B, JAMES S, AGEWALL S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Rev Esp Cardiol (Engl Ed), 2017, 70(12): 1082.
|
| [6] |
MICHNIEWICZ E, MLODAWSKA E, LOPATOWSKA P, et al. Patients with atrial fibrillation and coronary artery disease-Double trouble[J]. Adv Med Sci, 2018, 63(1): 30-35. doi: 10.1016/j.advms.2017.06.005
|
| [7] |
GRANGER C B, GOLDBERG R J, DABBOUS O, et al. Predictors of hospital mortality in the global registry of acute coronary events[J]. Arch Intern Med, 2003, 163(19): 2345-2353. doi: 10.1001/archinte.163.19.2345
|
| [8] |
BATRA G, SVENNBLAD B, HELD C, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome[J]. Heart, 2016, 102(12): 926-933. doi: 10.1136/heartjnl-2015-308678
|
| [9] |
JABRE P, ROGER V L, MURAD M H, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis[J]. Circulation, 2011, 123(15): 1587-1593. doi: 10.1161/CIRCULATIONAHA.110.986661
|
| [10] |
GOETTE A, ECKARDT L, VALGIMIGLI M, et al. Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: entrust-AF PCI sub-analysis[J]. Clin Res Cardiol, 2021, 110(6): 831-840. doi: 10.1007/s00392-020-01760-4
|
| [11] |
MELGAARD L, GORST-RASMUSSEN A, LANE D A, et al. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation[J]. JAMA, 2015, 314(10): 1030-1038. doi: 10.1001/jama.2015.10725
|
| [12] |
PROIETTI M, FARCOMENI A, ROMITI G F, et al. Association between clinical risk scores and mortality in atrial fibrillation: systematic review and network meta-regression of 669, 000 patients[J]. Eur J Prev Cardiol, 2020, 27(6): 633-644. doi: 10.1177/2047487318817662
|
| [13] |
ROFFI M, PATRONO C, COLLET J P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2016, 37(3): 267-315. doi: 10.1093/eurheartj/ehv320
|
| [14] |
EAGLE K A, LIM M J, DABBOUS O H, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry[J]. JAMA, 2004, 291(22): 2727-2733. doi: 10.1001/jama.291.22.2727
|
| [15] |
BAEZA-ROMÁN A, DE MIGUEL-BALSA E, LATOUR-PÉREZ J, et al. Predictive power of the grace score in population with diabetes[J]. Int J Cardiol, 2017, 248: 73-76. doi: 10.1016/j.ijcard.2017.06.083
|
| [16] |
PAIVA L V, PROVIDENCIA R C, BARRA S N, et al. Cardiovascular risk assessment of pulmonary embolism with the GRACE risk score[J]. Am J Cardiol, 2013, 111(3): 425-431. doi: 10.1016/j.amjcard.2012.10.020
|
| [17] |
ÁLVAREZ-ÁLVAREZ B, RAPOSEIRAS-ROUBÍN S, ABU-ASSI E, et al. Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome[J]. Open Heart, 2014, 1(1): e000123. doi: 10.1136/openhrt-2014-000123
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: